Association of long noncoding RNA and c-JUN expression in hepatocellular carcinoma

References

• El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology. 2012;142(6):1264–73 e1.
   PubMed Web of Science ®Google Scholar
• Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108.
   PubMed Web of Science ®Google Scholar
• Selvapatt N, House H, Brown A. Hepatocellular carcinoma surveillance: are we utilizing it? J Clin Gastroenterol. 2016 Jan;50(1):e8–e12.
   Google Scholar
• Wong GL. Optimal surveillance program for hepatocellular carcinoma - getting ready, but not yet. World J Hepatol. 2015;7(18):2133–2135.
   PubMedGoogle Scholar
• NCCN clinical practice guidelines in oncology (NCCN guidelines ®) hepatobiliar cancers. National Comprehensive Cancer Network ®. Version 2.2015. 2015.
   Google Scholar
• Yu TT, Xu XM, Hu Y, et al. Long noncoding RNAs in hepatitis B virus-related hepatocellular carcinoma. World J Gastroenterol: WJG. 2015;21(23):7208–7217.
   PubMed Web of Science ®Google Scholar
• Sze KM, Chu GK, Lee JM, et al. C-terminal truncated hepatitis B virus x protein is associated with metastasis and enhances invasiveness by C-Jun/matrix metalloproteinase protein 10 activation in hepatocellular carcinoma. Hepatology. 2013;57(1):131–139.
   PubMed Web of Science ®Google Scholar
• Hagiwara S, Kudo M, Chung H, et al. Activation of c-Jun N-terminal kinase in non-cancerous liver tissue predicts a high risk of recurrence after hepatic resection for hepatocellular carcinoma. Hepatol Res. 2012;42(4):394–400.
   PubMed Web of Science ®Google Scholar
• Abdou AG, Abd-Elwahed M, Badr M, et al. The differential immunohistochemical expression of p53, c-Jun, c-Myc, and p21 between HCV-related hepatocellular carcinoma with and without cirrhosis. Appl Immunohistochem Mol Morphol. 2016 Feb;24(2):75–87.
   PubMedGoogle Scholar
• Maeda S. c-Jun NH(2)-terminal kinase may predict hepatocellular carcinoma recurrence. Hepatol Res. 2012;42(4):349–350.
   PubMed Web of Science ®Google Scholar
• Kung JTY, Colognori D, Lee JT. Long noncoding RNAs: past, present, and future. Genetics. 2013;193:651–669.
   PubMed Web of Science ®Google Scholar
• Collins JF. Long noncoding RNAs and hepatocellular carcinoma. Gastroenterology. 2015;148(2):291–294.
   PubMed Web of Science ®Google Scholar
• Amicone L, Citarella F, Cicchini C. Epigenetic regulation in hepatocellular carcinoma requires long noncoding RNAs. Biomed Res Int. 2015;2015:473942.
   PubMed Web of Science ®Google Scholar
• Orom UA, Derrien T, Beringer M, et al. Long noncoding RNAs with enhancer-like function in human cells. Cell. 2010;143:46–58.
   PubMed Web of Science ®Google Scholar
• Mohamadkhani A. Long noncoding RNAs in interaction with RNA binding proteins in hepatocellular carcinoma. Hepat Mon. 2014;14(5):e18794.
   Google Scholar
• Llovet JM, Brú C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis. 1999;19(3):329–338.
   PubMed Web of Science ®Google Scholar
• Child CG, Turcotte JG. Surgery and portal hypertension. Major ProblClinSurg. 1964;1:1–85.
   Google Scholar
• Pugh RN, Murray-Lyon IM, Dawson JL, et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973;60:646–649.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta deltaC(T)) method. Methods. 2001;25:402–408.
   PubMed Web of Science ®Google Scholar
• Mehta A, Singal AG. Hepatocellular carcinoma surveillance: does alpha-fetoprotein have a role? Gastroenterology. 2015;149(3):816–817.
   PubMedGoogle Scholar
• Rg G. Early detection of hepatocellular carcinoma through surveillance using biomarkers. Gastroenterol Hepatol (N Y). 2014;10(2):121–123.
   PubMedGoogle Scholar
• Ma L, Chua MS, Andrisani O, et al. Epigenetics in hepatocellular carcinoma: an update and future therapy perspectives. World J Gastroenterol: WJG. 2014;20(2):333–345.
   PubMed Web of Science ®Google Scholar
• Li G, Zhang H, Wan X, et al. Long noncoding RNA plays a key role in metastasis and prognosis of hepatocellular carcinoma. Biomed Res Int. 2014;2014:780521.
   PubMed Web of Science ®Google Scholar
• Sun J, Bie B, Zhang S, et al. Long non-coding RNAs: critical players in hepatocellular carcinoma. Int J Mol Sci. 2014;15(11):20434–20448.
   PubMed Web of Science ®Google Scholar
• Li C, Chen J, Zhang K, et al. Progress and prospects of long noncoding RNAs (lncRNAs) in hepatocellular carcinoma. Cell Physiol Biochem. 2015;36(2):423–434.
   PubMed Web of Science ®Google Scholar
• Shibata C, Otsuka M, Kishikawa T, et al. Diagnostic and therapeutic application of noncoding RNAs for hepatocellular carcinoma. World J Hepatol. 2015;7(1):1–6.
   PubMedGoogle Scholar
• Wang F, Ying HQ, He BS, et al. Upregulated lncRNA-UCA1 contributes to progression of hepatocellular carcinoma through inhibition of miR-216b and activation of FGFR1/ERK signaling pathway. Oncotarget. 2015;6:7899–7917.
   PubMed Web of Science ®Google Scholar
• Wang Y, Chen W, Yang C, et al. Long non-coding RNA UCA1 (CUDR) promotes proliferation and tumorigenesis of bladder cancer. Int J Oncol. 2012;41:276–284.
   PubMed Web of Science ®Google Scholar
• Han Y, Yang YN, Yuan HH, et al. UCA1, a long non- coding RNA up-regulated in colorectal cancer influences cell proliferation, apoptosis and cell cycle distribution. Pathology. 2014;46:396–401.
   PubMed Web of Science ®Google Scholar
• Li JY, Ma X, Zhang CB. Overexpression of long non-coding RNA UCA1 predicts a poor prognosis in patients with esophageal squamous cell carcinoma. Int J ClinExpPathol. 2014;7:7938–7944.
   Web of Science ®Google Scholar
• Huang J, Zhou N, Watabe K, et al. Long non-coding RNA UCA1 promotes breast tumor growth by suppression of p27 (Kip1). Cell Death Dis. 2014;5:e1008.
   PubMed Web of Science ®Google Scholar
• Kamel MM, Matboli M, Sallam M, et al. Investigation of long noncoding RNAs expression profile as potential serum biomarkers in patients with hepatocellular carcinoma. Transl Res. 2015 Oct 24; pii: S1931-5244(15)00335-7. doi:10.1016/j.trsl.2015.10.002.
   PubMed Web of Science ®Google Scholar
• Shaulian E, Schreiber M, Piu F, et al. The mammalian UV response: c-Jun induction is required for exit from p53-imposed growth arrest. Cell. 2000;103:897–908.
   PubMed Web of Science ®Google Scholar
• Wisdom R, Johnson RS, Moore C. c-Jun regulates cell cycle progression and apoptosis by distinct mechanisms. Embo J. 1999;18:188–197.
   PubMed Web of Science ®Google Scholar
• Mathas S, Hinz M, Anagnostopoulos I, et al. Aberrantly expressed c-Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF-κB. Embo J. 2002;21:4104–4113.
   PubMed Web of Science ®Google Scholar
• Mariani O, Brennetot C, Coindre JM, et al. JUN oncogene amplification and overexpression block adipocytic differentiation in highly aggressive sarcomas. Cancer Cell. 2007;11:361–374.
   PubMed Web of Science ®Google Scholar
• Rangatia J, Vangala RK, Singh SM, et al. Elevated c-Jun expression in acute myeloid leukemias inhibits C/EBPα DNA binding via leucine zipper domain interaction. Oncogene. 2003;22:4760–4764.
   PubMed Web of Science ®Google Scholar
• Hasselblatt P, Rath M, Komnenovic V, et al. Hepatocyte survival in acute hepatitis is due to c-Jun/AP-1-dependent expression of inducible nitric oxide synthase. Proc Natl AcadSci U S A. 2007 Oct 23;104(43):17105–17110. Epub 2007 Oct 16.
   PubMed Web of Science ®Google Scholar
• Endo M, Yasui K, Nakajima T, et al. Infrequent amplification of JUN in hepatocellular carcinoma. Anticancer Res. 2009 Dec;29(12):4989–4994.
   PubMed Web of Science ®Google Scholar
• Trierweiler C, Hockenjos B, Zatloukal K, et al. The transcription factor c-JUN/AP-1 promotes HBV-related liver tumorigenesis in mice. Cell Death Differ. 2015 Oct 16. doi:10.1038/cdd.2015.121.
   PubMed Web of Science ®Google Scholar
• Yuen MF, Wu PC, Lai VC, et al. Expression of c-Myc, c-Fos, and c-jun in hepatocellular carcinoma. Cancer. 2001 Jan 1;91(1):106–112.
   PubMed Web of Science ®Google Scholar
• Eferl R, Ricci R, Kenner L, et al. Liver tumor development. c-Jun antagonizes the proapoptotic activity of p53. Cell. 2003 Jan 24;112(2):181–192.
   PubMed Web of Science ®Google Scholar
• Vance KW, Ponting CP. Transcriptional regulatory functions of nuclear long noncoding RNAs. Trends Genet. 2014 Aug;30(8):348–355. doi:10.1016/j.tig.2014.06.001. Epub 2014 Jun 25. Review.
   PubMed Web of Science ®Google Scholar